Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Mirati Therapeutics (MRTX)

$104.33 0.00 (0.00%)

17:35 EST MRTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $104.33

Market Cap 3.36B

PE Ratio -40.71

EPS -2.562953

Volume (Avg. Vol.)

Day's Range 104.33 - 104.33

52-Week Range 34.39 - 111.99

Dividend & Yield N/A (N/A)

MRTX Stock Predictions, Articles, and Mirati Therapeutics News

From InvestorPlace
From the Web

The 10 Best Stocks for 2019 — So Far

By James Brumley, InvestorPlace Feature Writer Jun 4, 2019

Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019.

Best & Worst Performing Mid Cap Stocks for November 12, 2019

From StockNews.com Nov 12, 2019

BGNE – BGNE leads the way today as the best performing mid cap stock, closing up 37.02%.

Best & Worst Performing Mid Cap Stocks for November 11, 2019

From StockNews.com Nov 11, 2019

BGNE – BGNE leads the way today as the best performing mid cap stock, closing up 37.02%.

3 Cancer Treatment Stocks to Buy Right Now

From The Motley Fool Nov 9, 2019

MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.

Best & Worst Performing Mid Cap Stocks for November 8, 2019

From StockNews.com Nov 8, 2019

BGNE – BGNE leads the way today as the best performing mid cap stock, closing up 37.02%.

Best & Worst Performing Mid Cap Stocks for November 7, 2019

From StockNews.com Nov 7, 2019

BGNE – BGNE leads the way today as the best performing mid cap stock, closing up 37.02%.

Mirati Therapeutics, Inc. Just Reported And Analysts Have Been Cutting Their Estimates

From Simply Wall St Nov 7, 2019

Mirati Therapeutics, Inc. (NASDAQ:MRTX) just released its latest third-quarter results and things are looking bullish. Revenues of US$988k beat estimates by a substantial 370% margin. Unfortunately, Mirati Therapeutics also reported<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrtx/mirati-therapeutics/news/mirati-therapeutics-inc-just-reported-and-analysts-have-been-cutting-their-estimates/">Read More...</a></div>

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!